153 related articles for article (PubMed ID: 26091795)
1. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
2. BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions.
Sinha A; Paul BT; Sullivan LM; Sims H; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
Oncotarget; 2017 Feb; 8(6):10114-10135. PubMed ID: 28052035
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs.
Hashimoto N; Tsunedomi R; Yoshimura K; Watanabe Y; Hazama S; Oka M
BMC Cancer; 2014 Sep; 14():722. PubMed ID: 25260650
[TBL] [Abstract][Full Text] [Related]
5. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance.
Ryoo IG; Choi BH; Ku SK; Kwak MK
Redox Biol; 2018 Jul; 17():246-258. PubMed ID: 29729523
[TBL] [Abstract][Full Text] [Related]
6. Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
Hepburn AC; Veeratterapillay R; Williamson SC; El-Sherif A; Sahay N; Thomas HD; Mantilla A; Pickard RS; Robson CN; Heer R
PLoS One; 2012; 7(11):e50690. PubMed ID: 23226356
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer.
Garza-Treviño EN; Martínez-Rodríguez HG; Delgado-González P; Solís-Coronado O; Ortíz-Lopez R; Soto-Domínguez A; Treviño VM; Padilla-Rivas GR; Islas-Cisneros JF; Quiroz-Reyes AG; Said-Fernández SL
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396431
[TBL] [Abstract][Full Text] [Related]
8. Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
Hu J; Li J; Yue X; Wang J; Liu J; Sun L; Kong D
Oncotarget; 2017 Apr; 8(17):28463-28470. PubMed ID: 28212529
[TBL] [Abstract][Full Text] [Related]
9. Stem cell markers: A guide to neoadjuvant therapy in breast carcinomas.
Gucin Z; Buyukpinarbasili N; Gecer MO; Ersoy YE; Turk HM; Yildiz S; Aksoy DO
Indian J Pathol Microbiol; 2023; 66(3):495-501. PubMed ID: 37530329
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer.
Li Y; Yang X; Geng C; Liu Y; Tang T; Zhang L; Liu F; Zhang M; Hao J; Ma L
Front Immunol; 2024; 15():1390261. PubMed ID: 38726001
[TBL] [Abstract][Full Text] [Related]
11. Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation.
Ramović Hamzagić A; Cvetković D; Gazdić Janković M; Milivojević Dimitrijević N; Nikolić D; Živanović M; Kastratović N; Petrović I; Nikolić S; Jovanović M; Šeklić D; Filipović N; Ljujić B
Curr Oncol; 2024 Feb; 31(3):1221-1234. PubMed ID: 38534924
[TBL] [Abstract][Full Text] [Related]
12. Identifying and targeting tumor-initiating cells in the treatment of breast cancer.
Wei W; Lewis MT
Endocr Relat Cancer; 2015 Jun; 22(3):R135-55. PubMed ID: 25876646
[TBL] [Abstract][Full Text] [Related]
13. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.
Rychtarcikova Z; Lettlova S; Tomkova V; Korenkova V; Langerova L; Simonova E; Zjablovskaja P; Alberich-Jorda M; Neuzil J; Truksa J
Oncotarget; 2017 Jan; 8(4):6376-6398. PubMed ID: 28031527
[TBL] [Abstract][Full Text] [Related]
14. Mammosphere formation assay from human breast cancer tissues and cell lines.
Lombardo Y; de Giorgio A; Coombes CR; Stebbing J; Castellano L
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867607
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of MDR transport in tumor-initiating cells.
Koshkin V; Yang BB; Krylov SN
PLoS One; 2013; 8(11):e79222. PubMed ID: 24223908
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 Expression as a Potential Survival Predictor in Human Gliomas.
Raguž M; Tarle M; Müller D; Tomasović-Lončarić Č; Chudy H; Marinović T; Chudy D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542090
[TBL] [Abstract][Full Text] [Related]
17. Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer.
Jiang T; Shi W; Natowicz R; Ononye SN; Wali VB; Kluger Y; Pusztai L; Hatzis C
BMC Genomics; 2014 Oct; 15(1):876. PubMed ID: 25294321
[TBL] [Abstract][Full Text] [Related]
18. Association of
Justo-Garrido M; López-Saavedra A; Alcaraz N; Cortés-González CC; Oñate-Ocaña LF; Caro-Sánchez CHS; Castro-Hernández C; Arriaga-Canon C; Díaz-Chávez J; Herrera LA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003293
[TBL] [Abstract][Full Text] [Related]
19. Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance.
Ng CKY; Weigelt B; A'Hern R; Bidard FC; Lemetre C; Swanton C; Shen R; Reis-Filho JS
Cancer Res; 2014 Jun; 74(11):2946-2961. PubMed ID: 24706696
[TBL] [Abstract][Full Text] [Related]
20. Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer.
Souto EP; Gong P; Landua JD; Srinivasan RR; Ganesan A; Dobrolecki LE; Purdy SC; Ford HL; Lewis MT
bioRxiv; 2023 Sep; ():. PubMed ID: 37745510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
